AcadeMab Biomedical Inc.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Private
- Established
- 2020-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.academab.com
Safety of AM-928 Infusion in Advanced Solid Tumors
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- AcadeMab Biomedical Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT05687682
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath